True Diagnostics, Inc. announced today that it has been awarded a Project Award through the Rapid Response Partnership Vehicle (RRPV) to advance the development of the VeriClear EbV MARV Rapid Antigen ...

Not every test result going in the wrong direction means we have to ... Think of the concept of delta prostate-specific ...

The California-based firm said that its VeriClear EbV MARV Rapid Antigen Test will be used for the detection and differentiation of Ebola and Marburg virus infections.

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

My doctor was of the opinion that over-medicalisation of patients was a common problem, and that a high PSA reading might ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...

A new vaccine can effectively prevent multiple types of cancer, with up to 88 percent efficacy for some forms of tumor in ...

In addition, Cupid is in the final stages of securing CE (EU IVDR) Certification for its HIV 1 & 2 Antibody and Hepatitis B Antigen IVD kits, expected by December 2025 -- products that address some of ...

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...

The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.